160 related articles for article (PubMed ID: 2114284)
1. Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo.
Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Friedrich E; Lehmann J; Keppler D
Eur J Biochem; 1990 May; 190(1):11-9. PubMed ID: 2114284
[TBL] [Abstract][Full Text] [Related]
2. In vivo metabolism and UTP-depleting action of 2-deoxy-2-fluoro-D-galactose.
Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Keppler D
Adv Enzyme Regul; 1990; 30():231-42. PubMed ID: 2403033
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of 2-deoxy-2-[18F]fluoro-D-galactose in the liver by phosphate and uridylate trapping.
Ishiwata K; Ido T; Imahori Y; Yamaguchi K; Fukuda H; Tada M; Matsuzawa T
Int J Rad Appl Instrum B; 1988; 15(3):271-6. PubMed ID: 3260229
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein N-glycosylation by 2-deoxy-2-fluoro-D-galactose.
Gross V; Hull WE; Berger U; Andus T; Kreisel W; Gerok W; Keppler D
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):821-6. PubMed ID: 1497619
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism.
Ishiwata K; Tomura M; Ido T; Iwata R; Itoh J; Kameyama M
Int J Rad Appl Instrum B; 1989; 16(8):775-81. PubMed ID: 2621112
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-2-[18F]fluoro-D-galactose: a new tracer for the measurement of galactose metabolism in the liver by positron emission tomography.
Fukuda H; Matsuzawa T; Tada M; Takahashi T; Ishiwata K; Yamada K; Abe Y; Yoshioka S; Sato T; Ido T
Eur J Nucl Med; 1986; 11(11):444-8. PubMed ID: 3486765
[TBL] [Abstract][Full Text] [Related]
7. 2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography.
Ishiwata K; Yamaguchi K; Kameyama M; Fukuda H; Tada M; Matsuzawa T; Muraishi K; Itoh J; Kawashima K; Takahashi T
Int J Rad Appl Instrum B; 1989; 16(3):247-54. PubMed ID: 2785512
[TBL] [Abstract][Full Text] [Related]
8. Uridylate trapping, induction of UTP deficiency, and stimulation of pyrimidine synthesis de novo by D-galactosone.
Keppler DO; Schulz-Holstege C; Fauler J; Reiffen KA; Schneider F
Biochem J; 1982 Jul; 206(1):139-46. PubMed ID: 7126188
[TBL] [Abstract][Full Text] [Related]
9. Metabolic pathway of 2-deoxy-2-[18F]fluoro-D-talose in mice: trapping in tissue after phosphorylation by galactokinase.
Haradahira T; Maeda M; Kato A; Kanazawa Y; Yamada M; Torii Y; Ichiya Y; Masuda K
Nucl Med Biol; 1994 Feb; 21(2):269-76. PubMed ID: 9234293
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-D-galactose metabolism in ascites hepatoma cells results in phosphate trapping and glycolysis inhibition.
Smith DF; Keppler DO
Eur J Biochem; 1977 Feb; 73(1):83-92. PubMed ID: 190012
[TBL] [Abstract][Full Text] [Related]
11. The metabolism of 2-fluoro-2-deoxy-D-glucose in human chondrocytes and its incorporation into keratan sulfate proteoglycans.
Fedders G; Kock R; Van de Leur E; Greiling H
Eur J Biochem; 1994 Feb; 219(3):1063-71. PubMed ID: 8112319
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic synthesis of UDP-(3-deoxy-3-fluoro)-D-galactose and UDP-(2-deoxy-2-fluoro)-D-galactose and substrate activity with UDP-galactopyranose mutase.
Barlow JN; Blanchard JS
Carbohydr Res; 2000 Oct; 328(4):473-80. PubMed ID: 11093703
[TBL] [Abstract][Full Text] [Related]
13. 3-Fluoro-3-deoxy-D-galactose: a new probe for studies on sugar cataract.
Secchi EF; Lizak MJ; Sato S; Kador PF
Curr Eye Res; 1999 Apr; 18(4):277-82. PubMed ID: 10372987
[TBL] [Abstract][Full Text] [Related]
14. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
[TBL] [Abstract][Full Text] [Related]
15. Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses.
Paul R; Aho K; Bergman J; Haaparanta M; Kulmala J; Reissell A; Solin O
Int J Rad Appl Instrum B; 1989; 16(5):449-53. PubMed ID: 2509402
[TBL] [Abstract][Full Text] [Related]
16. Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Lattke H; Koch HK; Lesch R; Keppler DO
Virchows Arch B Cell Pathol Incl Mol Pathol; 1979 Jun; 30(3):297-312. PubMed ID: 43010
[TBL] [Abstract][Full Text] [Related]
17. A 19F NMR study of 2-deoxy-2-fluoro-D-galactose in mice.
Kanazawa Y; Kuribayashi S; Kojima M; Haradahira T
Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4213-6. PubMed ID: 3245998
[No Abstract] [Full Text] [Related]
18. [2-Deoxy-2-(18F)Fluoro-D-galactose: a new tracer for the evaluation of liver function by PET--I. Evaluation of toxicity and radiation dose].
Fukuda H; Yamaguchi K; Matsuzawa T; Abe Y; Yamada K; Yoshioka S; Sato T; Tada M; Ogata Y; Takahashi T
Kaku Igaku; 1987 Feb; 24(2):165-9. PubMed ID: 3497290
[No Abstract] [Full Text] [Related]
19. Cerebral metabolism of fluorodeoxyglucose measured with 19F NMR spectroscopy.
Pouremad R; Wyrwicz AM
NMR Biomed; 1991 Aug; 4(4):161-6. PubMed ID: 1931555
[TBL] [Abstract][Full Text] [Related]
20. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S
J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
